-
, aerosols and modelling based in Heidelberg A young, motivating and dynamic research team in a stimulating and internationally recognized environment for excellent research A modern research infrastructure
-
focusses on the development and translation of a novel peptide therapy against cardiac diseases. It is based on extensive preliminary work by our working group, which has demonstrated therapeutic effects
-
against cardiac diseases. It is based on extensive preliminary work by our working group, which has demonstrated therapeutic effects of the synthetic peptide in chronic and acute heart failure animal models
-
adults, characterised by severe genomic instability and a lack of targeted therapies. Using cutting-edge methods and unique primary patient-derived cell models, this project will seek to understand
-
models and human mucosa-associated microbiota. Details of the associated RTG2751 consortium and other related projects can be found at www.medizin.uni-halle.de/grk2751 Your Profile Completed excellent
-
for 3 years with starting date based on mutual agreement (possible from July/Aug. 2025). The remuneration is based on TV-L E13. Application deadline: June 30th, 2025 Interested? Please send applications
-
chemistry) We offer an international and attractive work environment in Heidelberg (research group Mastalerz). The salary is based on TV-L scale (E13). The position is limited to two years, with
-
ClpL function as superior protein disaggregases and provide extreme heat resistance to bacteria by reactivating aggregated proteins. They protect bacterial pathogens against temperature-based